• Annexin V-PE Apoptosis Detection Kit: Rapid Live-Cell Analys

  2026-05-13

  Experience swift, fixation-free apoptosis detection in live cells with the Annexin V-PE Apoptosis Detection Kit. This workflow-ready solution empowers researchers to quantify early apoptotic events with precision, streamlining both flow cytometry and fluorescence microscopy assays.

• Applied Metabolism Research Using the DiscoveryProbe Library

  2026-05-13

  The DiscoveryProbe Metabolism-related Compound Library empowers researchers to dissect metabolic pathways with precision and reproducibility. This article guides you through optimized workflows, troubleshooting, and advanced applications, translating recent clinical insights into actionable bench protocols.

• ATG4B Nuclear Translocation Links Energy Deficiency to DNA R

  2026-05-12

  This study uncovers a mechanistic link between energy deficiency and impaired DNA repair in acute myeloid leukemia (AML). The authors demonstrate that nuclear translocation of ATG4B under energy stress inhibits PRMT1-mediated methylation of MRE11, thereby compromising DNA repair and accelerating leukemia progression. These insights reveal a new metabolic-genomic interface relevant for cancer biology and therapeutic targeting.

• LY294002: Applied Strategies for PI3K/Akt/mTOR Pathway Inhib

  2026-05-12

  LY294002 empowers researchers with precise, reversible PI3K/Akt/mTOR inhibition, facilitating robust studies of apoptosis, autophagy, and fibrosis. This guide translates recent reference breakthroughs and workflow best practices into actionable protocols and troubleshooting insights.

• BMX-IN-1: Optimizing BMX Kinase Inhibition in Cancer & Infec

  2026-05-11

  BMX-IN-1 delivers highly selective, irreversible BMX kinase inhibition for robust cell-based studies across oncology and infectious disease models. Its nanomolar potency and proven role in modulating lysosomal acidification empower researchers to dissect complex signaling pathways and therapeutic targets with confidence.

• Palonosetron Hydrochloride: Innovations in CINV Prevention a

  2026-05-11

  This article examines Ruhlmann & Herrstedt's systematic review of palonosetron hydrochloride for preventing chemotherapy-induced nausea and vomiting (CINV), highlighting its pharmacological distinctions and clinical impact relative to other 5-HT3 antagonists. We discuss the methodological rigor, key findings, and practical relevance for researchers, particularly in the context of preclinical and translational oncology workflows.

• Pterostilbene Protects Blood–Brain Barrier via Wnt Pathway M

  2026-05-10

  This study demonstrates that pterostilbene, a natural resveratrol analogue, protects the blood–brain barrier after ischemic stroke by targeting early cytoskeletal changes and late basement membrane degradation. The findings clarify a dual-phase mechanism involving actin dynamics and Wnt/β-catenin signaling, with implications for developing new treatments for cerebral ischemia.

• Lipid Nanoparticle Design Shapes mRNA Delivery and Immunogen

  2026-05-09

  This study demonstrates that the structure of lipid nanoparticles and the route of administration critically influence the efficacy and safety of mRNA delivery during pregnancy. Mechanistic insights clarify how specific LNP features affect transfection efficiency, innate immune responses, and maternal-fetal outcomes, guiding future therapeutic designs for pregnancy-related disorders.

• Pexidartinib (PLX3397): Targeted CSF1R Inhibitor for Oncolog

  2026-05-08

  Pexidartinib (PLX3397) is a potent, selective CSF1R inhibitor that modulates tumor-associated macrophages, enabling tumor microenvironment research and apoptotic assays. APExBIO provides this molecule for preclinical oncology workflows, supporting reproducible, high-specificity macrophage modulation.

• MEK1/2 and c-Myc-Max Control of TERT Transcription in hESCs

  2026-05-08

  This study uncovers a cooperative mechanism between MEK1/2 kinases and the c-Myc:MAX complex in preventing polycomb-mediated repression of TERT, the telomerase catalytic subunit gene, in human pluripotent stem cells. These findings clarify key epigenetic and transcriptional processes regulating telomerase, with implications for stem cell biology and telomere-related disease research.

• A-1210477: Next-Generation MCL-1 Inhibitor for Functional Ca

  2026-05-07

  Explore how the selective MCL-1 inhibitor A-1210477 enables advanced, mechanistically informed apoptosis induction in cancer cells. This in-depth article reveals unique experimental considerations and clinical insights beyond standard apoptosis assays.

• Sulfo-NHS-SS-Biotin: Precision Biotinylation for Protein Pur

  2026-05-07

  Sulfo-NHS-SS-Biotin empowers surface-selective, reversible protein labeling with unmatched workflow flexibility—transforming affinity purification, proteostasis, and interactome mapping. Discover experimentally validated protocols, troubleshooting strategies, and emerging applications that set this cleavable biotin disulfide N-hydroxysulfosuccinimide ester apart.

• Energy Deficiency, ATG4B, and DNA Repair in Leukemia Progres

  2026-05-06

  This study identifies a mechanistic link between cellular energy deficiency and impaired DNA repair in acute myeloid leukemia (AML). The authors reveal that nuclear translocation of ATG4B inhibits PRMT1-mediated methylation of MRE11, promoting genomic instability and disease progression, highlighting new therapeutic vulnerabilities in cancer metabolism.

• Epalrestat: Aldose Reductase Inhibitor for Metabolic Disease

  2026-05-06

  Epalrestat from APExBIO enables precise inhibition of the polyol pathway and potent activation of antioxidant defenses, empowering advanced research in diabetic complications, neurodegeneration, and emerging cancer metabolism models. Its high purity, reproducible solubility in DMSO, and validated mechanism make it a standout choice for oxidative stress and metabolic pathway studies.

• Tioconazole: Mechanistic Insights and Next-Gen Antifungal Re

  2026-05-05

  Explore how Tioconazole, a leading antifungal medication, offers novel mechanistic insights for advanced antifungal drug development and fungal infection models. This article delivers a scientific deep dive beyond conventional workflows.

12914 records 1/861 page Next 12345 下5页 Last page